The first step in creating your TD2 De-Risk plan is through our unique "Oncology Roundtables" that bring together numerous experts to establish a starting point for the De-Risk process. Subsequently, TD2 integrates genomic tools, computational modeling, access to multiple clinical sites (and molecular diagnostics), biobanking, and regulatory expertise.

For more information contact Debbie Snyder at dsnyder@tgen.org or 602-358-8315.